[HTML][HTML] Glioblastoma Therapy: Past, Present and Future
E Obrador, P Moreno-Murciano… - International Journal of …, 2024 - mdpi.com
Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …
Although great efforts have been made by clinicians and researchers, no significant …
[HTML][HTML] Immuno-PET for Glioma Imaging: An Update
Despite significant advances in glioma diagnosis and treatment, overall outcomes remain
suboptimal. Exploring novel therapeutic avenues show promise in advancing the field …
suboptimal. Exploring novel therapeutic avenues show promise in advancing the field …
[HTML][HTML] The application of radionuclide therapy for breast cancer
Radionuclide-mediated diagnosis and therapy have emerged as effective and low-risk
approaches to treating breast cancer. Compared to traditional anatomic imaging techniques …
approaches to treating breast cancer. Compared to traditional anatomic imaging techniques …
Navigating the landscape of theranostics in nuclear medicine: current practice and future prospects
A Shah, A Dabhade, H Bharadia, PS Parekh… - … für Naturforschung C, 2024 - degruyter.com
Theranostics refers to the combination of diagnostic biomarkers with therapeutic agents that
share a specific target expressed by diseased cells and tissues. Nuclear medicine is an …
share a specific target expressed by diseased cells and tissues. Nuclear medicine is an …
[PDF][PDF] Discovery of novel macrocyclic peptide radioligands for tumor therapy by mRNA display
A Jaekel, K Sherry, P Desai, D Fox… - Cancer …, 2024 - ariceum-therapeutics.com
Radioligand therapeutics (RLT) aim to selectively deliver radioisotopes to cancer tissues to
eradicate tumor cells while limiting the damage to surrounding tissues. The therapeutic …
eradicate tumor cells while limiting the damage to surrounding tissues. The therapeutic …
[HTML][HTML] Targeted Nuclear Medicine. Achievements, Challenges and Prospects
MV Kovalchuk, SM Deyev, KA Sergunova - Nanobiotechnology Reports, 2023 - Springer
The path of the development of nuclear medicine at the international level and that in Russia
is presented. Significant achievements in the development and establishment of nuclear …
is presented. Significant achievements in the development and establishment of nuclear …
Theranostics in Nuclear Medicine
PO Rumyantsev, KA Sergunova, AL Konevega… - Nanobiotechnology …, 2023 - Springer
The advantages of personalized medicine and modern technologies of targeted nuclear
medicine are presented. Examples of the most efficient theranostic pairs in the treatment of …
medicine are presented. Examples of the most efficient theranostic pairs in the treatment of …
[PDF][PDF] The application of radionuclide therapy for breast cancer
A radionuclide is a nuclide carrying excess nuclear energy that can emit either alpha
particles carrying high energy with a short range, beta particles carrying low energy with a …
particles carrying high energy with a short range, beta particles carrying low energy with a …
Таргетная ядерная медицина. Достижения, проблемы и перспективы
МВ Ковальчук, СМ Деев, КА Сергунова - Российские нанотехнологии, 2023 - elibrary.ru
Представлен путь развития ядерной медицины на международном и отечественном
уровнях. Представлены значимые достижения в развитии и становлении ядерно …
уровнях. Представлены значимые достижения в развитии и становлении ядерно …
Dosimetry and biodistribution of actinium radiopharmaceuticals for targeted alpha therapy
HM Koniar - 2024 - open.library.ubc.ca
Targeted alpha therapy (TAT) combines an alpha emitting radioisotope with an appropriate
biological targeting molecule to selectively bind to cancer cells and deliver highly localised …
biological targeting molecule to selectively bind to cancer cells and deliver highly localised …